Destiny Pharma Plc

Destiny Pharma (DEST)

Company name:Destiny Pharma Plc
EPIC:DESTTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BDHSP575
Market Segment:ASQ1Share Type:DE
WWW Address:https://www.destinypharma.com/aim-rule-26/Description:ORD GBP0.01
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 41.50 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 40.00 43.00 41.50 41.50 41.50 2,399
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 18.18 43.82 0.11 -11.90 - - - 85.50 - 34.50

Destiny Pharma Key Figures

(at previous day's close)
Market Cap.18.18m
Shares In Issue43.82m
Prev. Close41.50
PE Ratio- 
Dividend Yield-%
EPS - basic-11.90p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-10.78p
Return On Equity (ROE)-42.15%
Operating Margin-%
PEG Factor- 
EPS Growth Rate-41.67%
Dividends PS Growth Rate-%
Net Debt-6.26m
Gross Gearing6.14%
Quick Assets13.03m
Net Working Capital12.23m
Intangibles / Fixed Assets-%
Turnover PS-p
Pre-Tax Profit PS-13.71p
Retained Profit PS-11.79p
Cash PS16.12p
Net Cash PS14.29p
Net Tangible Asset Value PS *27.97p
Net Asset Value PS27.97p
Spread3.00 (6.98%) 

Destiny Pharma Balance Sheet

LSE:DEST:Liabilities+EQLSE:DEST:Assets

Share Price Performance

Sample Period HighLow
1 week41.5040.50
4 weeks43.5039.50
12 weeks43.5038.50
1 year85.5034.50

Share Price Chart (5 years)

Destiny Pharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week40.501.002.4740.500.0041.50
4 weeks41.50--39.500.0241.47
12 weeks41.50--38.500.0141.01
26 weeks78.50-37.00-47.1334.500.0243.45
1 year68.50-27.00-39.4234.500.0257.33
3 years158.50-117.00-73.8234.500.02109.01
5 years158.50-117.00-73.8234.500.02109.01

Destiny Pharma Key Management Ratios

Destiny Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 1.21 
Tobin's Q Ratio (excl. intangibles)1.21 
Dividend Yield-%
Market-to-Book Ratio1.48 
Price-to-Pre-Tax Profit PS-3.03 
Price-to-Retained Profit PS-3.52 
Price-to-Cash Flow PS-3.85 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS1.48 
Price-to-Cash PS2.58 
Net Working Capital PS27.90 
Price Pct to Working Capital PS1.49%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Destiny Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-47.93%
Net Gearing (excl. Intangibles)-47.93%
Gross Gearing6.14%
Gross Gearing (excl. Intangibles)6.14%
Gearing Under 1 Year6.14%
Gearing Under 1 Year (excl. Intgbl)6.14%
Assets/Equity1.07 
Cash/Equity57.61 
(Liquidity Ratios)
Net Working Capital to Total Assets93.63%
Current Ratio16.25 
Quick Ratio (Acid Test)16.25 
Liquidity Ratio8.81 
Cash & Equiv/Current Assets54.20%
(Solvency Ratios)
Enterprise Value11.12m
CFO/Sales- 
CFO/Attributable Profit- 
CFO/Assets-0.36 
CFO/Debt-5.89 
Total Debt/Equity Market Value0.04 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.13 
Total Debt0.80m
Total Debt/Net Current Assets0.07%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs1 
Beta (60-Mnth)Beta (36-Mnth)
0.11200.1120

Destiny Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-49.02%
Return On Assets (ROA)-34.28%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-42.15%
Return On Investment (ROI)-35.70%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debtors-to-Sales-%
Debt Collection Period-Days

Destiny Pharma Dividends

Sorry No Data Available

Destiny Pharma Fundamentals

 31 Dec 2017 (GBP)31 Dec 2018 (GBP)
turnover----m
pre tax profit-3.21--6.01-m
attributable profit-2.98--5.17-m
retained profit-2.98--5.17-m
eps - basic (p)-8.40 -11.90 
eps - diluted (p)-8.40 -11.90 
dividends per share- - 

Destiny Pharma Balance Sheet

 31 Dec 2017 (GBP)31 Dec 2018 (GBP)
LSE:DEST:Liabilities+EQLSE:DEST:AssetsLSE:DEST:Liabilities+EQLSE:DEST:Assets
 31 Dec 2017 (GBP)31 Dec 2018 (GBP)
ASSETS
fixed assets fixed assets0.020.13%0.030.23%m
intangibles intangibles--%--%m
fixed investments fixed investments--%--%m
current assets - other current assets - other5.0029.27%5.0038.29%m
stocks stocks--%--%m
debtors debtors0.341.97%0.977.41%m
cash & securities cash & securities11.7268.63%7.0654.07%m
TOTAL17.08100%13.06100%m
LIABILITIES
creditors - short creditors - short0.402.33%0.806.14%m
creditors - long creditors - long--%--%m
creditors - other creditors - other--%--%m
subordinated loans subordinated loans--%--%m
insurance funds insurance funds--%--%m
TOTAL0.402.33%0.806.14%m
EQUITY
ord cap, reserves ord cap, reserves16.6997.67%12.2693.86%m
prefs, minorities prefs, minorities--%--%m
TOTAL16.6997.67%12.2693.86%m
OTHER
NAV Basic- - 
NAV Diluted- - 

Destiny Pharma Cash Flow Statement

31 Dec 2017 (GBP)31 Dec 2018 (GBP)
Operating CF-2.15-4.72m
Pre-Financing CF-7.17-4.66m
Retained CF10.24-4.66m

Destiny Pharma Brokers

Broker infomation is not available for this class of stock.
Your Recent History
LSE
DEST
Destiny Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191209 04:27:19